Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1,948 DKK | -0.29% | +0.39% | -9.88% |
11:54am | Truist Securities Raises Price Target on Genmab to $53 From $50, Maintains Buy Rating | MT |
03/06 | Genmab's Tisotumab Shows 'Encouraging' Antitumor Activity in Phase 2 Head, Neck Cancer Study | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.88% | 1.83TCr | |
+15.57% | 12TCr | |
+13.63% | 11TCr | |
-4.60% | 2.48TCr | |
+1.40% | 2.25TCr | |
-42.28% | 1.63TCr | |
-16.01% | 1.53TCr | |
+4.08% | 1.41TCr | |
+26.35% | 1.17TCr | |
+78.80% | 901.9Cr |
- Stock Market
- Equities
- GMAB Stock
- News Genmab A/S
- Genmab A/S : quaterly earnings release